Investors Sue Fertility Treatment Co. Following FDA Letter
OvaScience Inc. and its top brass were hit with a putative shareholder class action Monday following a company announcement that it was suspending trials of its flagship fertility treatment because of...To view the full article, register now.
Already a subscriber? Click here to view full article